Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Müller, Sören ^a,b   Nowak, Katharina ^a  

^a GOETHE UNIVERSITY   (Germany)

^b GENXPRO GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; MESSENGER RNA; MICRORNA; MICRORNA 106A 5P; MICRORNA 106B 3P; MICRORNA 10B 3P; MICRORNA 135A 5P; MICRORNA 142 5P; MICRORNA 206; MICRORNA 21 5P; MICRORNA 210; MICRORNA 216B; MICRORNA 24; MICRORNA 3065; MICRORNA 3065 5P; MICRORNA 361 3P; MICRORNA 363 3P; MICRORNA 500 3P; MICRORNA 508 5P; MICRORNA 509 5P; MICRORNA 590; MICRORNA 660 5P; MICRORNA 99A; SCATTER FACTOR RECEPTOR; SMALL NUCLEOLAR RNA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UNTRANSLATED RNA; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; RNA; TRANSCRIPTOME;

ANGIOGENESIS; ARTICLE; CARCINOGENESIS; COMPUTER MODEL; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; METASTASIS POTENTIAL; NUCLEOTIDE SEQUENCE; RNA SEQUENCE; UPREGULATION; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; KIDNEY TUMOR; PROCEDURES; SEQUENCE ANALYSIS;

CARCINOMA, RENAL CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; KIDNEY NEOPLASMS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; RNA, NEOPLASM; SEQUENCE ANALYSIS, RNA; TRANSCRIPTOME;

EID: 84902190467     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/948408     Document Type: Article

References (54)

1. Lipworth L., Tarone R. E., McLaughlin J. K., The epidemiology of renal cell carcinoma. Journal of Urology 2006 176 6 2353 2358 2-s2.0-33750499711 10.1016/j.juro.2006.07.130 (Pubitemid 44665976)
2. Ruppert-Kohlmayr A. J., Uggowitzer M., Meissnitzer T., Ruppert G., Differentiation of renal clear cell carcinoma and renal papillary carcinoma using quantitative CT enhancement parameters. The American Journal of Roentgenology 2004 183 5 1387 1391 2-s2.0-16544388346 (Pubitemid 44210606)
3. Cheville J. C., Lohse C. M., Zincke H., Weaver A. L., Blute M. L., Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. The American Journal of Surgical Pathology 2003 27 5 612 624 2-s2.0-0037407573 10.1097/00000478-200305000-00005 (Pubitemid 36514472)
4. Steffens S., Janssen M., Roos F. C., Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma-a multicentre study. European Journal of Cancer 2012 48 15 2347 2352 10.1016/j.ejca.2012.05.002
5. Waalkes S., Roos F. C., Eggers H., Schumacher S., Janssen M., Wegener G., Thüroff J. W., Hofmann R., Schrader M., Kuczyk M. A., Schrader A. J., Incidence and long-term prognosis of papillary renal cancer: results of a retrospective multicenter study. Der Urologe 2011 50 9 1125 1129 2-s2.0-80755172270 10.1007/s00120-011-2684-6
6. Djuranovic S., Nahvi A., Green R., miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science 2012 336 6078 237 240 2-s2.0-84859632747 10.1126/science.1215691
7. Khella H. W. Z., White N. M. A., Faragalla H., Gabril M., Boazak M., Dorian D., Khalil B., Antonios H., Bao T. T., Pasic M. D., Honey R. J., Stewart R., Pace K. T., Bjarnason G. A., Jewett M. A. S., Yousef G. M., Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses. Tumor Biology 2012 33 1 131 140 2-s2.0-83655184642 10.1007/s13277-011-0255-5
8. Huang Q. B., Ma X., Zhang X., Down-regulated miR-30a in clear cell renal cell carcinoma correlated with tumor hematogenous metastasis by targeting angiogenesis-specific DLL4. PLoS ONE 2013 8 6 e67294
9. Khella H. W. Z., Bakhet M., Allo G., miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma. Carcinogenesis 2013 34 10 2231 2239 10.1093/carcin/bgt184
10. Maute R. L., Schneider C., Sumazin P., tRNA-derived microRNA modulates proliferation and the DNA damage response and is down-regulated in B cell lymphoma. Proceedings of the National Academy of Sciences 2013 110 4 1404 1409 10.1073/pnas.1206761110
11. Chen J., Zhang D., Zhang W., Clear cell renal cell carcinoma associated microRNA expression signatures identified by an integrated bioinformatics analysis. Journal of Translational Medicine 2013 11 1, article 169 10.1186/1479-5876-11-169
12. Osanto S., Qin Y., Buermans H. P., Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing. PLoS ONE 2012 7 6 e38298
13. Zhou L., Chen J., Li Z., Li X., Hu X., Huang Y., Zhao X., Liang C., Wang Y., Sun L., Shi M., Xu X., Shen F., Chen M., Han Z., Peng Z., Zhai Q., Chen J., Zhang Z., Yang R., Ye J., Guan Z., Yang H., Gui Y., Wang J., Cai Z., Zhang X., Integrated profiling of MicroRNAs and mRNAs: MicroRNAs Located on Xq27.3 associate with clear cell renal cell carcinoma. PLoS ONE 2010 5 12 2-s2.0-78651253572 10.1371/journal.pone.0015224 e15224
14. Müller S., Rycak L., Winter P., omiRas: a Web server for differential expression analysis of miRNAs derived from small RNA-Seq data. Bioinformatics 2013 29 20 2651 2652 10.1093/bioinformatics/btt457
15. Yue J., Guan J., Wang X., MicroRNA-206 is involved in hypoxia-induced pulmonary hypertension through targeting of the HIF-1 α /Fhl-1 pathway. Laboratory Investigation 2013 93 7 748 759 10.1038/labinvest.2013.63
16. Wozniak M. B., le Calvez-Kelm F., Abedi-Ardekani B., Integrative genome-wide gene expression profiling of clear cell renal cell carcinoma in Czech Republic and in the United States. PLoS ONE 2013 8 3 e57886
17. Martin M., Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. Journal 2011 17 1
18. Langmead B., Trapnell C., Pop M., Salzberg S. L., Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biology 2009 10 3, article R25 2-s2.0-62349130698 10.1186/gb-2009-10-3-r25
19. Karolchik D., Hinricks A. S., Furey T. S., Roskin K. M., Sugnet C. W., Haussler D., Kent W. J., The UCSC table browser data retrieval tool. Nucleic Acids Research 2004 32 D493 D496 2-s2.0-0347755531 (Pubitemid 38081706)
20. Anders S., Huber W., Differential expression analysis for sequence count data. Genome Biology 2010 11 10, article R106 2-s2.0-77958471357 10.1186/gb-2010-11-10-r106
21. Huang D. W., Sherman B. T., Tan Q., Kir J., Liu D., Bryant D., Guo Y., Stephens R., Baseler M. W., Lane H. C., Lempicki R. A., DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic acids research 2007 35 supplement 2 W169 W175 2-s2.0-34547589578 10.1093/nar/gkm415
22. Szklarczyk D., Franceschini A., Kuhn M., Simonovic M., Roth A., Minguez P., Doerks T., Stark M., Muller J., Bork P., Jensen L. J., Von Mering C., The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Research 2011 39 supplement 1 D561 D568 2-s2.0-78651324347 10.1093/nar/gkq973
23. Shannon P., Markiel A., Ozier O., Baliga N. S., Wang J. T., Ramage D., Amin N., Schwikowski B., Ideker T., Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Research 2003 13 11 2498 2504 2-s2.0-0242490780 10.1101/gr.1239303 (Pubitemid 37428274)
24. Saini H. K., Enright A. J., Griffiths-Jones S., Annotation of mammalian primary microRNAs. BMC Genomics 2008 9, article 564 2-s2.0-60849112259 10.1186/1471-2164-9-564
25. Xiao X., Tang C., Xiao S., Enhancement of proliferation and invasion by MicroRNA-590-5p via targeting PBRM1 in clear cell renal carcinoma cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2012 20 11 537 544 10.3727/096504013X13775486749335
26. Liu H., Brannon A. R., Reddy A. R., Alexe G., Seiler M. W., Arreola A., Oza J. H., Yao M., Juan D., Liou L. S., Ganesan S., Levine A. J., Rathmell W. K., Bhanot G. V., Identifying mRNA targets of microRNA dysregulated in cancer: With application to clear cell Renal Cell Carcinoma. BMC Systems Biology 2010 4, article 51 2-s2.0-77953677658 10.1186/1752-0509-4-51
27. White N. M. A., Bao T. T., Grigull J., Youssef Y. M., Girgis A., Diamandis M., Fatoohi E., Metias M., Honey R. J., Stewart R., Pace K. T., Bjarnason G. A., Yousef G. M., MiRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. Journal of Urology 2011 186 3 1077 1083 2-s2.0-80051551689 10.1016/j.juro.2011.04.110
28. Jung M., Mollenkopf H.-J., Grimm C., Wagner I., Albrecht M., Waller T., Pilarsky C., Johannsen M., Stephan C., Lehrach H., Nietfeld W., Rudel T., Jung K., Kristiansen G., MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. Journal of Cellular and Molecular Medicine 2009 13 9 B 3918 3928 2-s2.0-70350755290 10.1111/j.1582-4934.2009.00705.x
29. Yan D., Dong X. D., Chen X., Wang L., Lu C., Wang J., Qu J., Tu L., MicroRNA-1/206 targets c-met and inhibits rhabdomyosarcoma development. Journal of Biological Chemistry 2009 284 43 29596 29604 2-s2.0-70350383632 10.1074/jbc.M109.020511
30. Zhang X., Xu J., Wang J., Reduction of MicroRNA-206 contributes to the development of bronchopulmonary dysplasia through up-regulation of fibronectin 1. PLoS ONE 2013 8 9
31. Stahlhut C., Suárez Y., Lu J., miR-1 and miR-206 regulate angiogenesis by modulating VegfA expression in zebrafish. Development 2012 139 23 4356 4365 10.1242/dev.083774
32. Yang G., Zhang R., Chen X., Mu Y., Ai J., Shi C., Liu Y., Shi C., Sun L., Rainov N. G., Li H., Yang B., Zhao S., MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status. Journal of Molecular Medicine 2011 89 10 1037 1050 2-s2.0-80755140088 10.1007/s00109-011-0775-x
33. Grillari J., Hackl M., Grillari-Voglauer R., miR-17-92 cluster: ups and downs in cancer and aging. Biogerontology 2010 11 4 501 506 2-s2.0-77954945639 10.1007/s10522-010-9272-9
34. Li G., Luna C., Qiu J., Epstein D. L., Gonzalez P., Alterations in microRNA expression in stress-induced cellular senescence. Mechanisms of Ageing and Development 2009 130 11-12 731 741 2-s2.0-71849111080 10.1016/j.mad.2009.09. 002
35. Brown J. M., Wilson W. R., Exploiting tumour hypoxia in cancer treatment. Nature Reviews Cancer 2004 4 6 437 447 2-s2.0-2942590732 (Pubitemid 38745529)
36. Cardones A. R., Bañez L. L., VEGF inhibitors in cancer therapy. Current Pharmaceutical Design 2006 12 3 387 394 2-s2.0-33644851219 10.2174/138161206775201910
37. Zhang T., Liu M., Wang C., Lin C., Sun Y., Jin D., Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression. Anticancer Research 2011 31 11 3859 3863 2-s2.0-83055162537
38. Pennacchietti S., Michieli P., Galluzzo M., Mazzone M., Giordano S., Comoglio P. M., Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003 3 4 347 361 2-s2.0-0037478437 10.1016/S1535-6108(03)00085-0 (Pubitemid 38340304)
39. Cecchi F., Daniel C. R., Donald P. B., Targeting the HGF/Met signaling pathway in cancer therapy. Expert Opinion on Therapeutic Targets 2012 16 6 553 572
40. Sierra J. R., Ming-Sound T., c-MET as a potential therapeutic target and biomarker in cancer. Therapeutic Advances in Medical Oncology 2011 3 supplement 1 S21 S35
41. Wang R., Ferrell L. D., Faouzi S., Maher J. J., Michael Bishop J., Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice. Journal of Cell Biology 2001 153 5 1023 1033 2-s2.0-0035947770 10.1083/jcb.153.5.1023 (Pubitemid 34289241)
42. Akiyama S. K., Olden K., Yamada M., Fibronectin and integrins in invasion and metastasis. Cancer and Metastasis Reviews 1995 14 3 173 189 2-s2.0-0028808210 10.1007/BF00690290
43. Lee S. H., Lee Y. J., Han H. J., Role of hypoxia-induced fibronectin-integrin β 1 expression in embryonic stem cell proliferation and migration: involvement of PI3K/Akt and FAK. Journal of Cellular Physiology 2011 226 2 484 493 2-s2.0-78649643925 10.1002/jcp.22358
44. Jubb A. M., Strickland L. A., Liu S. D., Mak J., Schmidt M., Koeppen H., Neuropilin-1 expression in cancer and development. Journal of Pathology 2012 226 1 50 60 2-s2.0-82755184122 10.1002/path.2989
45. Pidgeon G. P., Barr M. P., Gray S., Neuropilin-1 mediated survival in lung cancer: differential regulation by hypoxia. AACR Meeting Abstracts 2006 47 1
46. Dittmer J., The biology of the Ets1 proto-oncogene. Molecular Cancer 2003 2 1, article 29 10.1186/1476-4598-2-29 (Pubitemid 38751468)
47. Oikawa M., Abe M., Kurosawa H., Hida W., Shirato K., Sato Y., Hypoxia induces transcription factor ETS-1 via the activity of hypoxia-lnducible factor-1. Biochemical and Biophysical Research Communications 2001 289 1 39 43 2-s2.0-0035941117 10.1006/bbrc.2001.5927 (Pubitemid 33108788)
48. Chen C. H., Thai P., Yoneda K., A peptide that inhibits function of Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) reduces lung cancer metastasis. Oncogene 2013 1 11 10.1038/onc.2013.336
49. Ord J. J., Streeter E. H., Roberts I. S. D., Cranston D., Harris A. L., Comparison of hypoxia transcriptome in vitro with in vivo gene expression in human bladder cancer. British Journal of Cancer 2005 93 3 346 354 2-s2.0-25144464638 10.1038/sj.bjc.6602666 (Pubitemid 43080037)
50. Hua Z., Lv Q., Ye W., Wong C. K. A., Cai G., Gu D., Ji Y., Zhao C., Wang J., Yang B. B., Zhang Y., Mirna-directed regulation of VEGF and other angiogenic under hypoxia. PLoS ONE 2006 1 1, article e116 2-s2.0-54949154476 10.1371/journal.pone.0000116
51. Ma X., Gao Y., Fan Y., Overexpression of E2F1 promotes tumor malignancy and correlates with TNM stages in clear cell renal cell carcinoma. PLoS ONE 2013 8 9 e73436
52. Campbell A. D., P-Rex1 cooperates with PDGFR β to drive cellular migration in 3D microenvironments. PLoS ONE 2013 8 1 e53982
53. Chiang H. R., Schoenfeld L. W., Ruby J. G., Auyeung V. C., Spies N., Baek D., Johnston W. K., Russ C., Luo S., Babiarz J. E., Blelloch R., Schroth G. P., Nusbaum C., Bartel D. P., Mammalian microRNAs: experimental evaluation of novel and previously annotated genes. Genes and Development 2010 24 10 992 1009 2-s2.0-77952368550 10.1101/gad.1884710
54. Liao D., Johnson R. S., Hypoxia: a key regulator of angiogenesis in cancer. Cancer and Metastasis Reviews 2007 26 2 281 290 2-s2.0-34547124062 10.1007/s10555-007-9066-y (Pubitemid 47101669)